Ginkgo Bioworks shares are trading higher Monday afternoon, up over 8%, following the announcement of a strategic partnership ...

Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...

Despite coming back in style, the dangers of tanning beds never went away, particularly one side effect that’s more than skin deep and literally changing DNA.

As of Wednesday, December 24, Inovio Pharmaceuticals, Inc.’s INO share price has surged by 5.13%, which has investors questioning if this is right time to sell.

Dive into the GameStop stock saga! Understand the WallStreetBets, Robinhood, and hedge fund drama explained simply. Learn ...

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

CRISPR Therapeutics reached a significant milestone a couple of years ago: its first product approval. The company’s stock, ...

As of Wednesday, December 24, Repare Therapeutics Inc.’s RPTX share price has surged by 19.82%, which has investors questioning if this is right time to sell.

A groundbreaking genetic study has revealed that Italians who reach 100 carry significantly more ancient Western hunter-gatherer DNA than their younger counterparts. The research, published in ...

TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight ...

As demand for artificial intelligence (AI) remains strong, investors are wondering who the biggest winners will be going into next year.

The latest announcement is out from Repare Therapeutics ( (RPTX) ).